Skip to main content
SpringerLink
Log in

Ticagrelor reduces bleeding versus ticagrelor plus aspirin

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Ticagrelor With Aspirin or Alone in High Risk Patients After Coronary Intervention

Reference

  • Baber U, et al. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. European Heart Journal 41: 3533-3545, No. 37, Oct 2020. Available from: URL: http://doi.org/10.1093/eurheartj/ehaa670

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ticagrelor reduces bleeding versus ticagrelor plus aspirin. Reactions Weekly 1828, 13 (2020). https://doi.org/10.1007/s40278-020-85089-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-85089-y

Search

Navigation